Gerresheimer ramps up glass vial production
Germany glassware company Gerresheimer has opened a cleanroom production facility at its Polish subsidiary Polfa, aimed at the production of pharmaceutical vials.
Archives for June 15, 2005
ML Labs buys Quadrant to boost inhaler presence
UK pharmaceutical company ML Laboratories has acquired Quadrant Technologies, a company specialising in drug formulation and stabilisation, for £46.7 million (€70m), boosting its capabilities in the development of inhaled medicines, reports Phil Taylor.
Pfizer, Vicuron in $1.9 billion merger
Pfizer has struck a deal to buy Vicuron Pharmaceuticals, for $1.9 billion (€1.6 billion) in cash, in a move that places the drug company further into the realms of anti-infective R&D - an area thought to be falling out of favour in the pharmaceutical...
Alliance starts human TB drug testing
The Global Alliance for TB Drug Development has started testing a promising tuberculosis drug in humans. This development represents the first novel compound of a new class to be introduced for the treatment of TB in more than 40 years.
IDBS launches E-WorkBook
IDBS introduces the E-Workbook, an electronic laboratory notebook, which aims to provide a viable alternative in the way chemists, biologists and pharmacologists record, share and report all relevant experimental information.
EU antitrust ruling leads to AstraZeneca fine
AstraZeneca has been fined a hefty €60 million by the European Commission for manipulating patent laws to keep competitors out of the market, marking the first occasion that antirust laws have been used to combat patent abuse.
FDA approves first-in-class antibiotic
The Food and Drug Administration's (FDA) approval of the first-in-class antibiotic, Tygacil (tigecycline), is set to provide doctors with an alternative treatment for skin and intra-abdominal infections that have previously been hampered by the...